# Open Monoclonal Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/open-monoclonal-technology

- Industry: Healthcare
- Headquarters: Palo Alto, US
- Website: www.openmonoclonaltechnology.com
- Total disclosed funding: $4.9M
- Latest round: Series B (Mar 24, 2011)
- Investors on record: 1

## About

Founded in 2007 and based in California, US, Open Monoclonal Technology, Inc., operates as a provider of biotechnology products and services that generates human monoclonal antibodies based on transgenic rats.

## Funding rounds

- Series B, Mar 24, 2011, $4.9M — Essex Woodlands

## Investors

- Essex Woodlands (https://capitalatlas.ai/funds/essex-woodlands) — Series B